20-34708788-G-C
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_021202.3(TP53INP2):āc.49G>Cā(p.Glu17Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000149 in 1,609,798 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_021202.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TP53INP2 | NM_021202.3 | c.49G>C | p.Glu17Gln | missense_variant | 3/5 | ENST00000374810.8 | NP_067025.1 | |
TP53INP2 | NM_001329429.2 | c.49G>C | p.Glu17Gln | missense_variant | 3/5 | NP_001316358.1 | ||
TP53INP2 | NM_001329430.2 | c.49G>C | p.Glu17Gln | missense_variant | 2/4 | NP_001316359.1 | ||
TP53INP2 | NM_001329431.2 | c.49G>C | p.Glu17Gln | missense_variant | 3/5 | NP_001316360.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TP53INP2 | ENST00000374810.8 | c.49G>C | p.Glu17Gln | missense_variant | 3/5 | 1 | NM_021202.3 | ENSP00000363943 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 151850Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000701 AC: 17AN: 242670Hom.: 0 AF XY: 0.0000152 AC XY: 2AN XY: 131392
GnomAD4 exome AF: 0.0000137 AC: 20AN: 1457948Hom.: 0 Cov.: 32 AF XY: 0.00000138 AC XY: 1AN XY: 724958
GnomAD4 genome AF: 0.0000263 AC: 4AN: 151850Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74178
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 28, 2021 | The c.49G>C (p.E17Q) alteration is located in exon 3 (coding exon 1) of the TP53INP2 gene. This alteration results from a G to C substitution at nucleotide position 49, causing the glutamic acid (E) at amino acid position 17 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at